RBC Capital analyst Brian Abrahams maintained a Buy rating on Hookipa Pharma (HOOK – Research Report) on October 16 and
Tag: Brian Abrahams
Theratechnologies (THTX) Gets a Hold Rating from RBC Capital
In a report issued on October 15, Brian Abrahams from RBC Capital maintained a Hold rating on Theratechnologies (THTX –
Analysts Offer Insights on Healthcare Companies: Corbus Pharmaceuticals (NASDAQ: CRBP) and RedHill Biopharma (NASDAQ: RDHL)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Corbus Pharmaceuticals (CRBP
RBC Capital Maintains Their Hold Rating on Enanta Pharmaceuticals (ENTA)
In a report released yesterday, Brian Abrahams from RBC Capital maintained a Hold rating on Enanta Pharmaceuticals (ENTA – Research
Analysts Offer Insights on Healthcare Companies: Biogen (NASDAQ: BIIB) and ACADIA Pharmaceuticals (NASDAQ: ACAD)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Biogen (BIIB –
Analysts Offer Insights on Healthcare Companies: Sarepta Therapeutics (NASDAQ: SRPT) and Exelixis (NASDAQ: EXEL)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Sarepta Therapeutics
Analysts Offer Insights on Healthcare Companies: Galapagos (NASDAQ: GLPG), DaVita (NYSE: DVA) and Pfizer (NYSE: PFE)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Galapagos (GLPG – Research Report),